4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-009991
CHIEF ACCOUNTING OFFICER gave up 2,084 shares (to pay taxes)
- CHIEF ACCOUNTING OFFICER acquired 4,920 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Option exercise | +2,557 | 30,000 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Option exercise | +2,363 | 32,363 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Shares withheld for taxes | −1,083 | $21.77 | $23,577 | 31,280 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Shares withheld for taxes | −1,001 | $21.77 | $21,792 | 30,279 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Grant or award · Share Option | +21,150 | 21,150 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Grant or award · Restricted Share Unit | +10,575 | 10,575 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Option exercise · Restricted Share Unit | −2,557 | 5,115 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2025-04-01 | Option exercise · Restricted Share Unit | −2,363 | 7,087 | D | ||
Loading xslF345X05/form4-04032025_080410.xml…